ulipristal acetate: Clinical Trials

56 trials of ulipristal acetate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 completed, 11 unknown, 5 terminated, 5 withdrawn. 20 Phase 4, 12 Phase 3, 9 Phase 2, 5 Phase 1, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 420Unknown 8, Completed 6, Terminated 3, Withdrawn 2, Recruiting 1
Phase 312Completed 9, Recruiting 1, Terminated 1, Withdrawn 1
Phase 29Completed 6, Recruiting 1, Unknown 1, Withdrawn 1
Phase 15Completed 3, Unknown 1, Withdrawn 1
Early Phase 12Completed 2
Not applicable2Completed 1, Unknown 1

Follow ulipristal acetate: new trials by email Literature Review of ulipristal acetate trials Research Report on ulipristal acetate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mammogram Pretreatment With Ulipristal Acetate
Biospecimen Collection, Magnetic Resonance Imaging, Mammogram - Mammography Screening, Breast Density
Phase 2RecruitingOHSU Knight Cancer Institute262026-08-212026-09-03
Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception
Levonorgestrel, Piroxicam, Ulipristal Acetate - Contraception
Phase 3RecruitingThe University of Hong Kong9802025-01-182026-05-14
Disparities in Emergency Contraceptive Metabolism Dictate Efficacy
Ulipristal acetate - Contraceptive Usage
Phase 4RecruitingOregon Health and Science University1402023-01-092026-07-09
Ulipristal Acetate for Use in Early Pregnancy Loss
Ulipristal Acetate Tablets, Misoprostol Pill - Missed Abortion, Anembryonic Pregnancy
Phase 2CompletedUniversity of North Carolina, Chapel Hill32022-05-112023-06-28
Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy
Ulipristal Acetate - Contraception, Contraceptive Usage
CompletedNorthwestern University752022-03-012025-04-27
Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive
Ulipristal acetate - Contraception, Healthy Female
Phase 2WithdrawnPremier Research2020-12-012025-11-20
Ovarian Function With ENG Implant and UPA Use
ENG implant, oral ulipristal acetate - Contraception
Early Phase 1CompletedUniversity of Utah402020-09-042024-07-12
Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding
UPA, TEA, Placebo (for UPA) - Heavy Menstrual Bleeding
Phase 1WithdrawnUniversity of Saskatchewan2020-01-012020-01-28
Advance Provision of Medication Abortion
Mifeprex® (Mifepristone 200 mg), Misoprostol 800 mcg, ella® (ulipristal acetate emergency contraception 30 mg) - Early Abortion
Phase 4WithdrawnUniversity of California, San Francisco2020-01-012019-05-30
Ulipristal Acetate in Symptomatic Uterine Fibroid
Ulipristal Acetate 5 mg - Uterine Fibroid, Heavy Menstrual Bleeding
Phase 4TerminatedMỹ Đức Hospital252019-10-232020-04-13
Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine Fibroids (LISA)
Ulipristal Acetate - Leiomyoma, Uterine, Liver Injury
TerminatedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau302019-05-232024-05-20
Ulipristal Acetate for Cervical Preparation
Ulipristal Acetate - Termination of Pregnancy
Early Phase 1CompletedStanford University132019-04-162020-07-01
Use of Ulipristal Acetate in Induction of Second Trimester Missed Abortion
Ulipristal Acetate, Misoprostol - Induction of Second Trimester Abortion
Phase 4CompletedAin Shams University242019-01-012021-08-04
Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg
Ulipristal Acetate, Levonorgestrel - Contraception
Phase 4TerminatedKimberly Myer5322018-07-122025-11-20
On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility
Ulipristal Acetate 30 MG Oral Tablet - Contraception
Phase 1CompletedStanford University122018-03-152019-06-25
Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
Ulipristal Acetate - Adenomyosis, Heavy Uterine Bleeding
Phase 4WithdrawnVanderbilt University Medical Center2018-02-012018-02-08
Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques
ULIPRISTAL ACETATE - Infertility, Female, Fibroid Uterus
CompletedASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO1272017-12-292019-01-09
Ulipristal Versus Placebo for Women With Bleeding Induced by Mirena
Ulipristal acetate, Placebo - Heavy Menstrual Bleeding, Abnormal Bleeding
Phase 4UnknownUniversity of Campinas, Brazil322017-07-012018-05-03
Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA
UPA-ECx1, UPA-ECx2 - Obesity, Contraception
Phase 4CompletedOregon Health and Science University642017-05-302024-02-06
A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
Use Phase (Ulipristal Acetate, 30 mg) - Emergency Contraception
Phase 3CompletedHRA Pharma12702017-05-232022-12-02

Showing 20 of 56. Sign in to see all of them.

Conditions studied

Leiomyoma (20)  ·  Menorrhagia (4)  ·  Infertility (3)  ·  Adenomyosis (2)  ·  Breast Neoplasms (2)  ·  Contraception Behavior (2)  ·  Dysmenorrhea (2)  ·  Hemorrhage (2)  ·  Infertility, Female (2)  ·  Uterine Hemorrhage (2)  ·  Abortion, Missed (1)  ·  Body Weight (1)  ·  Constipation (1)  ·  Dilatation, Pathologic (1)  ·  Endometriosis (1)

Sponsors

HRA Pharma (5)  ·  PregLem SA (5)  ·  University Magna Graecia (4)  ·  Allergan (3)  ·  Oregon Health and Science University (3)  ·  Columbia University (2)  ·  Northwestern University (2)  ·  Premier Research (2)  ·  Stanford University (2)  ·  The University of Hong Kong (2)  ·  ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO (1)  ·  Ain Shams University (1)  ·  Amsterdam UMC, location VUmc (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)

Countries

United States (26)  ·  Italy (6)  ·  Belgium (5)  ·  Spain (5)  ·  France (4)  ·  United Kingdom (4)  ·  Austria (3)  ·  Netherlands (3)  ·  Poland (3)  ·  Canada (2)  ·  Czechia (2)  ·  Dominican Republic (2)  ·  Germany (2)  ·  Hong Kong (2)  ·  Hungary (2)

Top investigators

Fulvio Zullo, MD,PhD (4)  ·  Roberta Venturella, MD (3)  ·  Anna Chan (2)  ·  Dr Elke Bestel (2)  ·  Abigail Liberty (1)  ·  Alison Edelman, MD (1)  ·  Almereau Prollius, MD (1)  ·  Amanda Yunker, DO (1)  ·  Ashley M Turner, MD MSc (1)  ·  Carlos Morente, MD (1)  ·  Carolyn L Westhoff, MD (1)  ·  Carolyn Westhoff, MD (1)

Results publications

PMID 22296075, PMID 24630081, PMID 30969201, PMID 31444600, PMID 18448745, PMID 20634186, PMID 22296076, PMID 24457604, PMID 25542821, PMID 25994664, PMID 26477496, PMID 29420395, PMID 30130351, PMID 30239831, PMID 30303900, PMID 30871768, PMID 31777949, PMID 32033718, PMID 35015210, PMID 35470225, PMID 35576349, PMID 38663539, PMID 42387351

NIH funding

1ZIAHD000637-17 (1), 2009 (1), 2014 (1), R01HD105866 (1)